/
/
PhD Program Grants

PhD Program Grants

A clinical PhD program in Experimental Medicine and Medical Humanities at the University of Insubria, Varese, Italy, is open for applications.

The Ph.D. program is designed to train students for research activity; it lasts at least three academic years, during which the students acquire the necessary skills to perform high-profile research activities; it is an essential first step towards an academic career.

The Ph.D. program is accessed through an entrance examination based on qualifications and oral or written tests: those holding a Master’s Degree or equivalent (Italian or foreign) may apply in accordance with the terms and conditions specified in the call, published every year, generally in July.

Ph. D. candidates from extra-UE Countries must apply for a Visa for Study reasons, then, once in Italy for a residence permit. All details are availble here.

All the details and applications to the PhD Program can be found here.

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Latest Updates

Figure 1 COST

It is with great pleasure that we anounce that Work Group 1’s IMMUPARKNET paper has been published in Brain, entitled: “The immune system in Parkinson’s...

The Art of Living

Short-term Scientific Missions (STSM) are institutional visits aimed at supporting individual mobility and fostering collaborations by allowing scientists to visit an institution and contribute to...

WG2 animal

We’re thrilled to share the latest publication from our Working Group 2 (WG2) at IMMUPARKNET COST Action 21117! Entitled “Experimental Models to Study Immune Dysfunction...

IMG_7150

🎉 Exciting News from IMMUPARKNET COST Action 21117 Annual Meeting! 🎉 This year’s IMMUPARKNET COST Action Annual Conference took place in the beautiful city of...

things to do in Belgrade

This year IMMUPARKNET COST Action Annual Conference will take place in the beatiful city of Belgrade, Republic of Serbia, at the Royal Inn Hotel, from...

ADPD

Last week, from 5 to 9 March, the groundbreaking series of Alzheimer’s and Parkinson’s disease (AD/PD 2024) conferences took place in Lisbon, at Centro de...